The Epstein-Barr Virus (EBV) market is estimated to be valued at USD 1.4 Billion in 2024 and is expected to reach USD 2.1 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.53% from 2024 to 2031. https://www.zupyak.com/p/4491809/t/the-global-epstein-barr-virus-ebv-market-will-witness-high-growth-due-to-rising-cancer-incidences